In what ways can the entry of advanced diabetes drugs like Ozempic change public health outcomes and healthcare costs in India?
Novo Nordisk has introduced Ozempic for type 2 diabetes in India. I want to explore both the benefits and possible challenges this might bring for patients, healthcare providers, and the government.